Verified ComparisonLast updated: 16 April 2026
CJC-1295 vs Sermorelin
Both are GHRH analogs, but CJC-1295 with DAC exhibits much longer half-life, enabling less-frequent dosing. Sermorelin has a shorter, more physiologic GH-release pattern.
CJC-1295
GH Releasing
4.3/ 5
A−
Sermorelin
GH Releasing
4.1/ 5
A−
Editor's note
CJC-1295 (with DAC) extends half-life significantly; sermorelin mimics natural GHRH kinetics.
| Criterion | CJC-1295 | Sermorelin |
|---|---|---|
| Mechanism | GHRH analog (long-acting) | GHRH analog (short-acting) |
| Half-life | 8+ days (with DAC) | 10–30 minutes |
| Dosing frequency | Once weekly to bi-weekly | Daily or multiple daily |
| GH release pattern | Sustained elevation | Pulsatile, physiologic |
| Regulatory status (AU) | Not approved | Defined indication pathway |
Frequently asked questions
Sermorelin's short half-life produces more physiologic pulsatile GH release.
Want to read the full reviews?